REVIEW
|
doi:10.20944/preprints202402.0976.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
bevacizumab; ovarian cancer; angiogenesis; VEGF
Online: 19 February 2024 (11:19:20 CET)